RUNX3 and CAMK2N1 hypermethylation as prognostic marker for epithelial ovarian cancer.
about
Genomic/Epigenomic Alterations in Ovarian Carcinoma: Translational Insight into Clinical PracticeTribbles 2 mediates cisplatin sensitivity and DNA damage response in epithelial ovarian cancer.Platinum(ii) O,S complexes as potential metallodrugs against Cisplatin resistance.Genome-wide association studies and epigenome-wide association studies go together in cancer control.Functional Analyses of RUNX3 and CaMKIINα in Ovarian Cancer Cell Lines Reveal Tumor-Suppressive Functions for CaMKIINα and Dichotomous Roles for RUNX3 Transcript Variants.PIWIL1/piRNA-DQ593109 Regulates the Permeability of the Blood-Tumor Barrier via the MEG3/miR-330-5p/RUNX3 Axis.
P2860
RUNX3 and CAMK2N1 hypermethylation as prognostic marker for epithelial ovarian cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
RUNX3 and CAMK2N1 hypermethylation as prognostic marker for epithelial ovarian cancer.
@en
type
label
RUNX3 and CAMK2N1 hypermethylation as prognostic marker for epithelial ovarian cancer.
@en
prefLabel
RUNX3 and CAMK2N1 hypermethylation as prognostic marker for epithelial ovarian cancer.
@en
P2093
P2860
P356
P1476
RUNX3 and CAMK2N1 hypermethylation as prognostic marker for epithelial ovarian cancer
@en
P2093
Herbert Diebolder
Ingo B Runnebaum
Lars Jansen
Matthias Dürst
P2860
P304
P356
10.1002/IJC.29690
P577
2015-07-28T00:00:00Z